Expedeon Signs Supply Deal for Colloidal Gold With Reszon Diagnostics

Sep 27, 2018

|

NEW YORK (360Dx) — Expedeon said today that it has signed a three-year supply agreement for its colloidal gold with Malaysia-based Reszon Diagnostics International.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Expedeon Signs Supply Deal for Colloidal Gold With Reszon Diagnostics

To read the full story....

Breaking News

RenalytixAI Expects $80.8M From US IPO

Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia

Novacyt Reports Sharp Increase in Preliminary H1 Revenues

Quest Reports Preliminary Q2 Revenues of $1.83B

Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark

OpGen to Distribute Menarini Silicon Cellsearch Platform in North America for COVID-19 Applications

Featured White Papers

Development of a Metagenomics-based Pathogen-Detection Assay for SARS-CoV-2 Research

What's Popular?

One of Four Coronavirus Antibody Tests Met UK Agency's Sensitivity Criteria in Head-to-Head Study

FDA Letter Warns About False-Positive Results From Becton Dickinson SARS-CoV-2 Test

FDA Grants EUA for UCSF, Broad Institute, BioSewoom Coronavirus Tests

SARS-CoV-2 Pandemic May Promote Progress in Paper MDx

Amid Interest Generated by Coronavirus Testing, IPO Window Open for Dx Firms in 2020

Sponsorships